Marlborough, MA, United States of America

Michael Z Hoemann

USPTO Granted Patents = 17 (Patent Applications = 8)

CIPO Patents = 1 (Patent Applications = 3)

EPO Patents = 1 (Patent Applications = 8)

Average Co-Inventor Count = 4.5

ph-index = 6

Forward Citations = 230(Granted Patents)

Location History:

Marlborough, MA (US) (2000 - 2013)
Shrewsbury, MA (US) (2014 - 2019)
Worcester, MA (US) (2023)

Company Filing History:

Abbott Laboratories Corporation

patents

Years Active: 2000-2023

Loading Chart...

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11767310 - Nicotinamide RIPK1 inhibitors (2023-09-26),

2. 10280184 - Heterocyclic kinase inhibitors (2019-05-07),

3. 9567339 - Primary carboxamides as BTK inhibitors (2017-02-14),

4. 9150592 - Heterocyclic nuclear hormone receptor modulators (2015-10-06),

5. 8785639 - Substituted dihydropyrazolo[3,4-D]pyrrolo[2,3-B]pyridines and methods of use thereof (2014-07-22),

6. 8551981 - [object Object] (2013-10-08),

7. 8188083 - Triazolopyridazines (2012-05-29),

8. 7692019 - Methods for the stereoselective synthesis of substituted piperidines (2010-04-06),

9. 7217823 - 4,4-Disubstituted piperidines, and methods of use thereof (2007-05-15),

10. 7005524 - Methods for the stereoselective synthesis of substituted piperidines (2006-02-28),

11. 6703508 - Methods for the stereoselective synthesis of substituted piperidines (2004-03-09),

12. 6656953 - 4,4-Disubstituted piperidines, and methods of use thereof (2003-12-02),

13. 6376670 - Quinoline-indole antimicrobial agents, uses and compositions related thereto (2002-04-23),

14. 6207679 - Antimicrobial agents uses and compositions related thereto (2001-03-27),

15. 6180640 - Di- and tetra-hydroquinoline-indole antimicrobial agents, uses and compositions related thereto (2001-01-30),

Title: The Innovative Contributions of Michael Z Hoemann

Introduction

Michael Z Hoemann is a prominent inventor based in Marlborough, MA (US), known for his significant contributions to the field of pharmaceuticals. With a total of 17 patents to his name, he has made remarkable advancements in the development of compounds that address various medical conditions.

Latest Patents

Among his latest patents are the Nicotinamide RIPK1 inhibitors, which include compounds of Formula (I) and their pharmaceutically acceptable salts. These compounds are useful as RIPK1 inhibitors and are part of pharmaceutical compositions aimed at treating Ulcerative Colitis. Another notable patent is for Heterocyclic kinase inhibitors, which provides compounds of Formula (I) along with their pro-drugs and biologically active metabolites. These compounds are designed to treat immunological and oncological conditions.

Career Highlights

Throughout his career, Michael has worked with several reputable companies, including Sepracor, Inc. and AbbVie Inc. His work has been instrumental in advancing pharmaceutical research and development.

Collaborations

Michael has collaborated with notable colleagues such as Gregory D Cuny and James R Hauske, contributing to the innovative projects in which he has been involved.

Conclusion

Michael Z Hoemann's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a key innovator. His work continues to impact the treatment of various medical conditions, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.